Generative AI for drug discovery
Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing its own internal pipeline.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 30, 2020 | Pre-seed | $210K | 1 | UBC Seed Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
UBC Seed Fund | Yes | Pre-seed |